Peptides are a diverse group of molecules. Some are established medicines for specific conditions; others are investigational or lack adequate evidence for a proposed use. A meaningful consultation starts with the exact substance and clinical question.
Not currently listed at Prague. The team can tell you where it is available and what the alternatives are.
At a glance
Scope and price are confirmed with the team before booking. Where a published price exists for your clinic, it is shown on the programme or clinic page.
The exact test or procedure, preparation, clinician and price are agreed for your location before booking.
In detail
“Peptide therapy” does not identify a common effect or level of safety. The active molecule, formulation and route determine the relevant evidence. A research-use label, a compounding service or an online testimonial does not establish that a substance is an approved or appropriate medicine for you.
The clinician should explain the proposed purpose, evidence in relevant people, alternatives, material risks and the actual clinical or research setting. For HLC care, the important outcome is an informed decision about a specific option, including when the available information is insufficient to proceed.
Confirm who is responsible, what oversight applies, how consent and follow-up work and what happens if a problem develops. Research participation requires a specific protocol and eligibility assessment. A catalogue entry does not establish availability or enrolment.
Questions people ask
Related services
Discuss your findings, priorities and next steps with a physician. Scope and appointment length are agreed for the selected service.
A clinician-led discussion of an individually configured care plan, with scope and responsibilities agreed in advance.
Research entries are discussed with the research team, separately from clinical care. Not currently listed at Prague. The team can tell you where it is available and what the alternatives are.
